William C. Rives, CFA
Portfolio Manager, Analyst
Mr. Rives is a Portfolio Manager of Putnam Research Fund and the Portfolio Manager of Putnam
BioRevolution™ ETF, which focuses on companies at the intersection of technology and biology. In
addition, Mr. Rives is an Analyst covering the health care and utilities sectors. He is responsible for
conducting fundamental analysis, developing insights on material sustainability issues, assessing
valuations, and making buy/sell recommendations for companies in the medical technology and life
sciences industries and all companies in the utilities sector. Previously at Putnam, Mr. Rives served as an
Equity Associate, covering multiple sectors. He has been in the investment industry since he joined
Putnam in 2013.
ETFs |
|---|
| Putnam BioRevolution ETF |
More from the Equity team
Why active over passive for small-cap investing
A wide range of possible outcomes, a multitude of negative earners, and significantly less Wall Street coverage are just a few of the reasons small-cap investors should consider active managers who could steer them toward better results.
ESG materiality | Analyzing the growing role of ESG factors in executive compensation
A rising number of S&P 500 companies are now tying ESG metrics to executive pay. Explore insights on how this impacts corporate goals and investment opportunities.
ESG Metrics | Impact report of sustainable investing strategies
Putnam Investments is pleased to share our 2023 Sustainability and Impact Report.
Economic moats | Active investors seek wider moats
Economic moats, also called business moats, are competitive advantages that help a company maintain long-term profits and market share over competitors.